J. Lipid Res.  Neurobiology of Lipids (ISSN1683-5506)
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


A more recent version of this article appeared on January 1, 2007

Papers In Press, published online ahead of print October 1, 2006
J. Lipid Res., doi:10.1194/jlr.M600113-JLR200
This Article
Right arrow Full Text (Accepted Manuscript)
Right arrow All Versions of this Article:
M600113-JLR200v1
48/1/185    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bhattacharyya, A. K.
Right arrow Articles by Connor, W. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bhattacharyya, A. K.
Right arrow Articles by Connor, W. E.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Submitted on March 7, 2006
Revised on September 29, 2006
Accepted on October 1, 2006

Cholestanol metabolism in patients with cerebrotendinous xanthomatosis: Absorption, turnover, tissue deposition and clues to pathological consequences

Ashim K. Bhattacharyya, Don S. Lin, and William E. Connor

Medicine/Clinical Nutrition, Oregon Health & Science University, PORTLAND, OR 97239

Corresponding Author: connorw{at}ohsu.edu

To study the metabolism of cholestanol in patients with cerebrotendinous xanthomatosis (CTX), we measured the cholestanol absorption, cholesterol and cholestanol turnover and the tissue content of sterols in two patients. Cholestanol absorption was about 5.0 percent. The rapid exchangeable pool of cholestanol was 233 mg, and the total exchangeable pool was 752 mg. The production rate of cholestanol in pool A was 39 mg/day. Cholestanol 4-C14 was detected in the xanthomas but neither 4-C14 cholestanol or 4-C14 cholesterol was detected in peripheral nerves biopsied 49 and 97 days after 4-14C-cholesterol given intravenously. Of the eighteen tissues analyzed at biopsy and autopsy, the cholestanol content varied from 0.09 mg/gm in psoas muscle to 76 mg/gm in a cerebellar xanthoma. With the assumption that cholestanol to cholesterol ratio is 1.0, the relative cholestanol to cholesterol ratio varied from 1.0 in plasma and liver to 30.0 in the cerebellar xanthoma; cholestanol was especially high in nerve tissue. Our data indicated that CTX patients absorb cholestanol from the diet. They have a higher than normal cholestanol production rate. Cholestanol was derived from cholesterol. In CTX patients, the blood-brain barrier was intact to the passage of 4-14C cholesterol and 4-14C cholestanol. The deposition of large amounts of cholestanol (up to 30 percent of total sterols in cerebellum) in nervous tissues must have an important role in the neurological symptoms in CTX patients. In view of the intact blood-brain barrier, several other explanations for the large amounts of cholestanol in the brain were postulated.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 All ASBMB Journals   Journal of Biological Chemistry 
 Molecular and Cellular Proteomics   ASBMB Today 
Copyright © 2006 by the American Society for Biochemistry and Molecular Biology.